TORONTO -- Health Canada authorized Moderna's updated COVID-19 vaccine that protects against currently circulating variants of the virus on Tuesday.
The mRNA vaccine, called Spikevax, has been reformulated to target the KP.2 subvariant of Omicron, the agency said.
It replaces the previous version of the vaccine that was released last year, which targeted the XBB.1.5 subvariant of Omicron.
Health Canada recently asked provinces and territories to get rid of their older COVID-19 vaccines to ensure the most current vaccine will be used during this fall's respiratory virus season.
Health Canada is also reviewing two other updated COVID-19 vaccines but has not yet authorized them. They are Pfizer's Comirnaty, which is also an mRNA vaccine, as well as Novavax's protein-based vaccine.
Moderna's vaccine is approved for adults and children six months of age and older, the company said in a news release Tuesday.
"With vaccines ready, Moderna will begin delivery of updated doses to the Public Health Agency of Canada, ensuring supply is available in time for provincial and territorial vaccination campaigns," the release said.
In May, the National Advisory Committee on Immunization issued guidance for use of updated COVID-19 vaccines this fall, pending their approval by Health Canada.
In that guidance, NACI strongly recommended updated COVID-19 vaccinations for all adults 65 and older, people living in long-term care and other group living settings, people with underlying conditions that put them at higher risk of severe illness, people from Indigenous and racialized communities, and those who are pregnant or who provide essential community services.
NACI also said all other adults and children six months or older should also be eligible for an updated COVID-19 vaccination this fall.
This report by The Canadian Press was first published Sept. 17, 2024.
Canadian Press health coverage receives support through a partnership with the Canadian Medical Association. CP is solely responsible for this content.
